Todd Shriber

Todd Shriber

InvestorPlace Contributor

Recent Articles

Dow Jones Today: Geopolitical Tensions Lead to a Tense Day for Stocks

By Todd Shriber, InvestorPlace Contributor

An airstrike that killed a deadly Iranian leader pressured riskier assets today while industrial stocks were hamped by weak data.

Chesapeake Energy Fighting Off Bankruptcy Doesn’t Make It a Buy

By Todd Shriber, InvestorPlace Contributor

Chesapeake Energy was recently able to avert bankruptcy, but that may be the best thing that can be said of the flailing energy producer.

Dow Jones Today: A Roaring Start to 2020

By Todd Shriber, InvestorPlace Contributor

Apple, Intel and Goldman Sachs, among others, propelled the Dow Jones Industrial Average higher in the first trading day of 2020.

3 of the Best Biotech ETFs on the Market

By Todd Shriber, InvestorPlace Contributor

The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.

Beyond Meat’s Rich Multiples, Looming Competitors Make It a Tough Buy

By Todd Shriber, InvestorPlace Contributor

Beyond Meat stock is richly valued and the company faces an array of competitive threats, prompting tepid reactions from analysts.

Load More